0253-2727
2014 Issue 12
..............page:1049-1052
Cellular immune function and its clinical implications in 45 patients with multiple myeloma
Ke Xiaoyan;,Li Haishen;,Wan Wenli;,Wang Jing;,Wang Yanfang;,Zhu Mingxia;
Ke Xiaoyan;,Li Haishen;,Wan Wenli;,Wang Jing;,Wang Yanfang;,Zhu Mingxia;
..............page:1053-1057
Characteristics and treatment outcomes in 822 adult patients with acute myeloid leukemia: a single center experience
gong ben fa ;, li wei ;, lin dong ;, liu bing cheng ;, liu kai qi ;, wang jin yu ;, wang ying ;, wei hui ;, zhou chun lin ;
gong ben fa ;, li wei ;, lin dong ;, liu bing cheng ;, liu kai qi ;, wang jin yu ;, wang ying ;, wei hui ;, zhou chun lin ;
..............page:1058-1064
Diagnostic performance and clinical correlation of serum vascular endothelial growth factor levels in patients with newly diagnosed POEMS syndrome
cai zuo ;, cao xin xin ;, duan ming hui ;, li jian ;, li tian jiao ;, wang zuo ;, zhang zuo ;, zhou dao bin ;
cai zuo ;, cao xin xin ;, duan ming hui ;, li jian ;, li tian jiao ;, wang zuo ;, zhang zuo ;, zhou dao bin ;
..............page:1065-1068
CSF3R, ASXL1, SETBP1, JAK2 V617F and CALR mutations in chronic neutrophilic leukemia
cui ya juan ;, jiang zuo ;, li bing ;, qin tie jun ;, xiao zhi jian ;, xu ze feng ;, zhang pei hong ;, zhang yue ;
cui ya juan ;, jiang zuo ;, li bing ;, qin tie jun ;, xiao zhi jian ;, xu ze feng ;, zhang pei hong ;, zhang yue ;
..............page:1069-1073
SHP-1 gene in the disease progression of chronic myeloid leukemia
Li Yinghua;,Luo Jianmin;,Pan Yuxia;,Shang Yintao;,Wang Xingzhe;,Yang Lin;
Li Yinghua;,Luo Jianmin;,Pan Yuxia;,Shang Yintao;,Wang Xingzhe;,Yang Lin;
..............page:1074-1078
Clinical analysis of lower doses rituximab for children primary immune thrombocytopenia
Chen Yunfei;,Huang Yueting;,Liu Wei;,Liu Xiaofan;,Xue Feng;,Yang Renchi;,Zhang Lei;
Chen Yunfei;,Huang Yueting;,Liu Wei;,Liu Xiaofan;,Xue Feng;,Yang Renchi;,Zhang Lei;
..............page:1079-1082
Outcomes of modified NHL-BFM-90 protocol for children and adolescents with lymphoblastic lymphoma
chen yan ;, lu su ying ;, sun zuo zuo ;, sun xiao fei ;, wang juan ;, xia zuo ;, zhang fei ;, zhen zi jun ;, zhu jia ;
chen yan ;, lu su ying ;, sun zuo zuo ;, sun xiao fei ;, wang juan ;, xia zuo ;, zhang fei ;, zhen zi jun ;, zhu jia ;
..............page:1083-1089
A comparable analysis of IPSS and IPSS-R for evaluating prognosis of myelodysplastic syndrome
cheng hui ;, gong sheng lan ;, lei zuo ;, song xian min ;, wang jian min ;, xu xiao zuo ;, yang jian min ;, zhang wei ping ;
cheng hui ;, gong sheng lan ;, lei zuo ;, song xian min ;, wang jian min ;, xu xiao zuo ;, yang jian min ;, zhang wei ping ;
..............page:1090-1094
Residual hematopoiesis is an important prognostic factor of immunosuppressive therapy in severe aplastic anemia
jing li ping ;, li yang ;, peng guang xin ;, wu zhi jie ;, yang wen zuo ;, ye lei ;, zhang li ;, zhao zuo ;, zhou kang ;
jing li ping ;, li yang ;, peng guang xin ;, wu zhi jie ;, yang wen zuo ;, ye lei ;, zhang li ;, zhao zuo ;, zhou kang ;
..............page:1095-1099
Chronic lymphocytic leukemia with concomitant chronic myeloid leukemia: a case report
Cui Lifen;,Liu Xuan;,Quan Bi;,Zhang Jihong;,Zhang Zhenzhong;
Cui Lifen;,Liu Xuan;,Quan Bi;,Zhang Jihong;,Zhang Zhenzhong;
..............page:1099
Clinical features and risk factors analysis of acute graft-versus-host disease in patients with related HLA-haploidentical non T cell-depleted in vitro peripheral hematopoietic stem cell transplantation
duan xian lin ;, jiang ming ;, li ling ;, qu jian hua ;, tian meng ;, wen bing zhao ;, xu jian li ;, xue wen zuo ;, yuan hai long ;
duan xian lin ;, jiang ming ;, li ling ;, qu jian hua ;, tian meng ;, wen bing zhao ;, xu jian li ;, xue wen zuo ;, yuan hai long ;
..............page:1100-1106
Clinical implications of tumor necrosis factor-α in lymphomas
Fang Zhihong;,Huang Yun;,Lin Zhijuan;,Su Rui;,Wang Sili;
Fang Zhihong;,Huang Yun;,Lin Zhijuan;,Su Rui;,Wang Sili;
..............page:1107-1110
Evaluation of the immune target effects of corticosteroids, rituximab or gamma globulin for treatment of immune thrombocytopenia
chen pei shuai ;, gu wei ;, guan jun ;, he bin ;, jiang yang wen ;, pei xiao ping ;, shan dan ;, sun mei ;, sun xing ;
chen pei shuai ;, gu wei ;, guan jun ;, he bin ;, jiang yang wen ;, pei xiao ping ;, shan dan ;, sun mei ;, sun xing ;
..............page:1111-1114
Clinical implications of immune paresis in symptomatic multiple myeloma patients
An Zhiming;,Li Feng;,Song Ping;,Wang Liping;,Zhai Yongping;,Zhao Qian;,Zhou Xiaogang;
An Zhiming;,Li Feng;,Song Ping;,Wang Liping;,Zhai Yongping;,Zhao Qian;,Zhou Xiaogang;
..............page:1115-1118
Reduced intensive chemotherapy for children with Down syndrome-associated acute leukemia: two cases report and literature review
Guan Xianmin;,Ran Yunni;,Wen Xianhao;,Xian Ying;,Xiao Jianwen;,Yu Jie;
Guan Xianmin;,Ran Yunni;,Wen Xianhao;,Xian Ying;,Xiao Jianwen;,Yu Jie;
..............page:1119-1121
Essential thrombocythemia with JAK2 V617F mutation transformed into acute myeloid leukemia without JAK2 V617F mutation: case report and literature review
Chen Lijuan;,Li Jianyong;,Yu Wenjun;,Zhu Huayuan;
Chen Lijuan;,Li Jianyong;,Yu Wenjun;,Zhu Huayuan;
..............page:1122-1123
Blastic plasmacytoid dentritic cell neoplasm: two cases report and literature review
Bai Min;,Huang Yunpeng;,Su Liping;,Wang Jingrong;,Wang Lieyang;,Wang Lixia;,Zhang Zong;
Bai Min;,Huang Yunpeng;,Su Liping;,Wang Jingrong;,Wang Lieyang;,Wang Lixia;,Zhang Zong;
..............page:1124-1126
Current outlook on mutations of myeloproliferative neoplasms
Jin Jie;,Li Chenying;
Jin Jie;,Li Chenying;
..............page:1127-1130
Advances in immunotherapy for relapsed-refractory diffuse large B cell lymphoma
Chen Jiao;,Li Lijuan;,Zhang Liansheng;
Chen Jiao;,Li Lijuan;,Zhang Liansheng;
..............page:1131-1133
Myeloma cancer stem cells: the new target for multiple myeloma
Gao Lu;,Shi Jumei;,Zhan Fenghuang;
Gao Lu;,Shi Jumei;,Zhan Fenghuang;
..............page:1134-1137